These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23743961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children.
    Kavakli K, Yilmaz D, Cetinkaya B, Balkan C, Sözmen EY, Sağin FG.
    Pediatr Hematol Oncol; 2004; 21(5):403-10. PubMed ID: 15205083
    [Abstract] [Full Text] [Related]

  • 4. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
    Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):831-8. PubMed ID: 16225492
    [Abstract] [Full Text] [Related]

  • 5. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
    Sözmen EY, Kavakli K, Cetinkaya B, Akçay YD, Yilmaz D, Aydinok Y.
    Biol Trace Elem Res; 2003 Jul 01; 94(1):79-86. PubMed ID: 12907830
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC.
    J Assoc Physicians India; 2002 Feb 01; 50():279-80. PubMed ID: 12038667
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: oxidative stress markers and pregnancy outcome.
    Toblli JE, Cao G, Oliveri L, Angerosa M.
    Placenta; 2012 Feb 01; 33(2):81-7. PubMed ID: 22153683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC, Tian YC, Wu HH, Hsu PY, Huang JY, Chen YC, Fang JT, Yang CW.
    Int J Clin Pract; 2008 Mar 01; 62(3):416-22. PubMed ID: 17511797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Letter to the editor: treatment of iron deficiency anemia.
    Ozsoylu S.
    Pediatr Hematol Oncol; 2005 Mar 01; 22(7):645-6; author reply 647-8. PubMed ID: 16166057
    [No Abstract] [Full Text] [Related]

  • 18. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P, Gabbe EE, Fischer R, Heinrich HC.
    Arzneimittelforschung; 1994 Jun 01; 44(6):743-8. PubMed ID: 8053973
    [Abstract] [Full Text] [Related]

  • 19. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
    Jaber L, Rigler S, Taya A, Tebi F, Baloum M, Yaniv I, Haj Yehia M, Tamary H.
    J Pediatr Hematol Oncol; 2010 Nov 01; 32(8):585-8. PubMed ID: 20930652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.